Cytomegalovirus: virological facts for clinicians.
Human cytomegalovirus (HCMV) is a complex DNA virus encoding more than 200 viral proteins. This highly adapted opportunist agent has developed several ways to evade the immune system. Among all clinical features due to HCMV, retinitis occurs especially in severely immunosuppressed patients, particularly during the end phase of HIV infection. Highly active antiretroviral therapy (HAART) has significantly reduced the incidence of this complication. However, in this HAART era, we observe the emergence of new clinical patterns in patients presenting with cicatricial HCMV retinitis. These patterns could be potentially related to immune mechanisms directed against viral antigens expressed at the surface of retinal cells that are still latently infected without any viral replication. We used a model of human retinal pigment epithelial (RPE) cells to evaluate virus-host interactions in the presence of different cytokines in the eye which play a major role in immunological or infectious conditions. Two different enzymatic pathways seem to be particularly involved during infection. Lack of tryptophan and production of nitric oxide seem to block HCMV replication in RPE cells. We propose a model to explain some of the mechanisms involved during severe immunosuppression and also after immune recovery.
Bodaghi
B
B
Department of Ophthalmology, H¿opital Piti¿e-Salp¿etri¿ere, Paris, France. bodaghi@pasteur.fr
Michelson
S
S
D019380:Anti-HIV Agents / Q000627:therapeutic use; D016207:Cytokines / Q000502:physiology; D003587:Cytomegalovirus / Q000235:genetics / Q000254:growth & development / Q000502:physiology*; D003586:Cytomegalovirus Infections / Q000517:prevention & control; D006801:Humans; D010857:Pigment Epithelium of Eye / Q000166:cytology / Q000821:virology; D012173:Retinitis / Q000821:virology; D014779:Virus Replication / Q000502:physiology
D019380:Anti-HIV Agents; D016207:Cytokines